Aaron Sato
Chief Tech/Sci/R&D Officer en TWIST BIOSCIENCE CORPORATION .
Perfil
En la actualidad, Aaron K. Sato es Director Científico de Twist Bioscience Corp. En su trayectoria profesional anterior fue Vicepresidente de Investigación en Sutro Biopharma, Inc., Director Científico de LakePharma, Inc., Vicepresidente de Ciencias Proteicas en Surrozen, Inc., Director de Ingeniería de Anticuerpos en OncoMed Pharmaceuticals, Inc. y Director Senior de Descubrimiento en Dyax Corp. Aaron K. Sato se doctoró en el Instituto Tecnológico de Massachusetts y se licenció en la Universidad de Puget Sound.
Cargos activos de Aaron Sato
Empresas | Cargo | Inicio |
---|---|---|
TWIST BIOSCIENCE CORPORATION | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Aaron Sato.
Empresas | Cargo | Fin |
---|---|---|
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Chief Tech/Sci/R&D Officer | 01/06/2018 |
SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2017 |
ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2012 |
DYAX CORP. | Corporate Officer/Principal | 01/07/2006 |
Formación de Aaron Sato.
Massachusetts Institute of Technology | Doctorate Degree |
University of Puget Sound | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SUTRO BIOPHARMA, INC. | Health Technology |
TWIST BIOSCIENCE CORPORATION | Health Technology |
Empresas privadas | 4 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Aaron Sato